Influence of the vehicle on the properties and efficacy of microparticles containing amphotericin B

References

• Alle´mann E, Gurny R, Leroux JC. 1998. Biodegradable nano- particles of poly(lactic acid) and poly(lactic-co-glycolic acid) for parenteral administration. Pharmaceutical dosage forms: Dis- perse systems. Vol. 3. 2nd ed. Marcel Dekker Inc.
   Google Scholar
• Benelli P, Conti B, Genta I, Constantini M, Montanari L. 1998. Clonazepam microencapsulation in poly-D,L-lactide-co-glyco- lide microspheres. J Microencapsul 15:431–443.
   PubMed Web of Science ®Google Scholar
• Berman JD. 1997. Human leishmaniosis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24:684–703.
   PubMed Web of Science ®Google Scholar
• Bittner B, Kissel T. 1999a. Ultrasonic atomization for spray drying: A versatile technique for the preparation of protein loaded biodegradable microspheres. J Microencapsul 16:325–341.
   PubMed Web of Science ®Google Scholar
• Bittner B, Mader K, Kroll C, Borchert HH, Kissel T. 1999b. Tetracycline-HCl-loaded poly (DL-lactide-co-glycolide) micro- spheres prepared by a spray drying technique: influence of gamma-irradiation on radical formation and polymer degra- dation. J Control Rel 59:23–32.
   PubMed Web of Science ®Google Scholar
• Blanco-Prieto MJ, Besseghir K, Zerbe O, Andris D, Orsolini P, Heimgartner F, Merkle HP, Gander B. 2000. In vivo and in vitro evaluation of a somatostatin analogue released from PLGA microspheres. J Control Rel 67:19–28.
   PubMed Web of Science ®Google Scholar
• Brajtburg J, Elberg S, Kobayashi GS, Bolard J. 1994. Amphotericin B incorporated into egg lecithin-bile salt mixed micelles: Molecular and cellular aspects relevant to therapeutic efficacy in experimental mycoses. Antimicrob Agents Chemother 38:300–306.
   PubMed Web of Science ®Google Scholar
• Brophy MR, Deasy PB. 1988. Biodegradable polyester polymers as drug carriers. Encyclopedia of pharmaceutical technology. Vol. 2. 1st ed. Marcel Dekker Inc.
   Google Scholar
• Dang W, Daviau T, Brem H. 1996. Morphological characterization of polyanhydride biodegradable implant gliadel during in vitro and in vivo erosion using scanning electron microscopy. Pharm Res 13:683–691.
   PubMed Web of Science ®Google Scholar
• Deng JS, Li L, Tian Y, Meisters M, Chang HC, Stephens D, Chen S, Robinson D. 2001. The relationship between structures and in vitro properties of a polyanhydride implant containing gentamicin sulphate. Pharm Dev Technol 6:541–549.
   PubMed Web of Science ®Google Scholar
• Ernst C, Grange J. 1981. Structure of amphotericin B aggregates as revealed by UV and CD spectroscopies. Biopolymers 20:1575–1588.
   Web of Science ®Google Scholar
• Garc´ıadel Barrio G, Novo FJ, Irache JM. 2003. Loading of plasmid DNA into PLGA microparticles using TROMS (Total Recirculation One-Machine System): Evaluation of its integrity and controlled release properties. J Control Rel 86:123–130.
   Google Scholar
• Giunchedi P, Conti B, Genta I, Conte U, Puglisi G. 2001. Emulsion spray-drying for the preparation of albumin-loaded PLGA microspheres. Drug Dev Ind Pharm 27:745–750.
   PubMed Web of Science ®Google Scholar
• Hill JO, North RJ, Collins FM. 1983. Advantages of measuring changes in the number of viable parasites in murine models of experimental cutaneous leishmaniasis. Infect Immun 39:1087–1094.
   PubMed Web of Science ®Google Scholar
• Johansen P, Tamber H, Merkle HP, Gander B. 1999. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs. Eur J Pharm Biopharm 47:193–201.
   PubMed Web of Science ®Google Scholar
• Johansen P, Este´vez E, Zurbriggen R, Merkle HP, Gluck R, Corradin G, Gander B. 2000. Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres. Vaccine 19:1047–1054.
   PubMed Web of Science ®Google Scholar
• Katja´r M, Vikmon K, Morlin E, Szejtli J. 1989. Aggregation of amphotericin B in the presence of G-cyclodextrin. Biopolymers 28:1585–1586.
   PubMed Web of Science ®Google Scholar
• Kipper MJ, Shen E, Determan A, Narasimhan B. 2002. Design of an injectable system based on bioerodible polyanhydride microspheres for sustained drug delivery. Biomaterials 23:4405–4412.
   PubMed Web of Science ®Google Scholar
• Lacasse FX, Filion MC, Phillips NC, Escher E, McMullen JN, Hildgen P. 1998. Influence of surface properties at biodegrad- able microsphere surfaces: Effects on plasma protein adsorption and phagocytosis. Pharm Res 15:312–317.
   PubMed Web of Science ®Google Scholar
• Legrand P, Cheron M, Leroy L, Bolard J. 1997. Release of amphotericin B from delivery systems and its action against fungal and mammalian cells. J Drug Target 4:311–319.
   PubMed Web of Science ®Google Scholar
• Leong KW, Kost J, Mathiowitz E, Langer R. 1986. Polyanhydrides for controlled release of bioactive agents. Biomaterials 7:364–371.
   PubMed Web of Science ®Google Scholar
• Mohr D, Wolff M, Kissel T. 1999. Gamma radiation for terminal sterilization of 17beta-estradiol loaded poly-(D,L-lactide-co- glycolide) microparticles. J Control Rel 61:203–217.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. 2001. Fabrication, characterization and in vitro release of paclitaxel (Taxolw) loaded poly (lactic-co-glycolic acid) microspheres prepared by spray drying technique with lipid/cholesterol emulsifiers. J Control Rel 76:239–254.
   PubMed Web of Science ®Google Scholar
• Mullen AB, Carter KC, Baillie AJ. 1997. Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniosis. Antimicrob Agents Chemother 41:2089–2092.
   PubMed Web of Science ®Google Scholar
• Murillo M, Gamazo C, Gon˜ i MM, Irache JM, Blanco-Prieto MJ. 2002a. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis. Int J Pharm 242:341–344.
   Google Scholar
• Murillo M, Gon˜ i MM, Irache JM, Arangoa MA, Blasco JM, Gamazo C. 2002b. Modulation of the cellular immune response after oral or subcutaneous immunization with microparticles containing Brucella ovis antigens. J Control Rel 85:237–246.
   Google Scholar
• Nelson CL, Hickmon SG, Skinner RA. 1997. Treatment of experimental osteomyelitis by surgical debridement and the implantation of bioerodable, polyanhydride-gentamicin beads. J Orthop Res 15:249–255.
   PubMed Web of Science ®Google Scholar
• O’Hara P, Hickey AJ. 2000. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: Manufacture and characterization. Pharm Res 17:955–961.
   PubMed Web of Science ®Google Scholar
• Pavanetto F, Genta I, Giunchedi P, Conti B. 1993. Evaluation of spray drying as a method for polylactide and polylactide-co- glycolide microsphere preparation. J Microencapsul 10:487–497.
   PubMed Web of Science ®Google Scholar
• Prior S, Gamazo C, Irache JM, Merkle HP, Gander B. 2000. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int J Pharm 196:115–125.
   PubMed Web of Science ®Google Scholar
• Prior S, Gander B, Blarer N, Merkle HP, Subira´ ML, Irache JM, Gamazo C. 2002. In vivo phagocytosis and monocyte- macrophage activation with poly(lactide) and poly(lactide-co- glycolide) microspheres. Eur J Pharm Sci 15:197–207.
   PubMed Web of Science ®Google Scholar
• Rex JH, Walsh TJ. 1999. Estimating the true cost of amphotericin B. Clin Infect Dis 29:1408–1410.
   PubMed Web of Science ®Google Scholar
• Sa´nchez-Brunete JA, Dea MA, Rama S, Bola´s F, Alunda JM, Raposo R, Me´ndez MT, Torrado-Santiago, Torrado JJ. 2004a. Treatment of experimental visceral leishmaniasis with ampho- tericin B in stable albumin microspheres. Antimicrob Agents Chemother 48:3246–3252.
   PubMed Web of Science ®Google Scholar
• Sa´nchez-Brunete JA, Dea MA, Rama S, Bola´s F, Alunda JM, Torrado-Santiago, Torrado JJ. 2004b. Amphotericin B mole- cular organization as an essential factor to improve activity/toxi- city ratio in the treatment of visceral leishmaniasis. J Drug Target 12:453–460.
   PubMed Web of Science ®Google Scholar
• Tabata Y, Ikada Y. 1991. Phagocytosis of polymeric microspheres. In: Szycher M, editor. High performance biomaterials. Lancaster: Technomic Publishing. p 621–646.
   Google Scholar
• Tabata Y, Langer R. 1993b. Polyanhydride microspheres that display near-constant release of water-soluble model drug compounds. Pharm Res 10:391–399.
   PubMed Web of Science ®Google Scholar
• Tabata Y, Gutta S, Langer R. 1993a. Controlled delivery systems for proteins using polyanhydride microspheres. Pharm Res 10:487–496.
   PubMed Web of Science ®Google Scholar
• Takada S, Uda Y, Toguchi H, Ogawa Y. 1995. Application of a spray drying technique in the production of THR-containing injectable sustained-release microparticles of biodegradable polymers. PDA J Pharm Sci Technol 49:180–184.
   PubMedGoogle Scholar
• Thombre AG, Cardinal JR. 1988. Biopolymers for controlled drug delivery Encyclopedia of pharmaceutical technology. Vol 2. 1st ed. Marcel Dekker Inc.
   Google Scholar
• Titus RG, Marchand M, Boon T, Louis JA. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol 7:545–555.
   PubMed Web of Science ®Google Scholar
• Wagenaar BW, Muller BW. 1994. Piroxicam release from spray- dried biodegradable microspheres. Biomaterials 15:49–54.
   PubMed Web of Science ®Google Scholar
• Walter E, Dreher D, Kok M, Thiele L, Kiama SG, Gehr P, Merkle HP. 2001. Hydrophilic poly(DL-lactide-co-glycolide) micro- spheres for the delivery of DNA to human-derived macrophages and dendritic cells. J Control Rel 76:149–168.
   PubMed Web of Science ®Google Scholar
• Wong-Beringer A, Jacobs RA, Guglielmo BJ. 1998. Lipid formulations of amphotericin B: Clinical efficacy and toxicities. Clin Infect Dis 27:603–618.
   PubMed Web of Science ®Google Scholar
• Yang Z, Birkenhauer P, Julmy F, Chickering D, Ranieri JP, Merkle HPT, Luscher TF, Gander B. 1999. Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation. J Control Rel 60:269–277.
   PubMed Web of Science ®Google Scholar